FDA Classifies Sirolimus Test System Device into Class II Special Controls

Summary

The FDA has classified the sirolimus test system device as a Class II special control, requiring the use of a guidance document titled 'Class II Special Controls Guidance Document: Sirolimus Test Systems,' to ensure the device's safety and effectiveness in managing transplant therapy for patients receiving the immunosuppressive drug sirolimus.